Form D · Biotechnology
BioMarker Strategies LLC
Rockville, MD · CIK 0001387083
Offering snapshot reported Sep 6, 2016 · SEC filing
- Reported sold
- $525K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2016 | Initial | $525,000 | No comparison | 2 | SEC filing |
| Aug 26, 2015 | Initial | $0 | No comparison | 2 | SEC filing |
| Dec 3, 2013 | Initial | $125,000 | No comparison | 2 | SEC filing |
| Sep 28, 2011 | Amendment | $2,327,500 | $1,227,500vs Aug 19, 2011 | 17 | SEC filing |
| Aug 19, 2011 | Initial | $1,100,000 | No comparison | 12 | SEC filing |
| Nov 16, 2010 | Amendment | $2,012,121 | $897,121vs Aug 11, 2010 | 30 | SEC filing |
| Aug 11, 2010 | Initial | $1,115,000 | No comparison | 8 | SEC filing |
| Feb 16, 2010 | Initial | $273,178 | No comparison | 2 | SEC filing |
| Aug 13, 2009 | Initial | $439,400 | No comparison | 11 | SEC filing |
| Aug 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-270113
Source: Form D, filed Sep 6, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Allocco | Director |
| Paul Beresford | Director |
| Sam Broder | Director |
| Cy Cabradilla | Executive |
| Douglas Clark | Director |
| Jack Davis | Director |
| Joseph Klein | Director |
| Katarzyna Kusmierz | Director |
| Glenn Miller | Director |
| Karen Olson | Director, Executive, Promoter |
| Jerry Parrott | Director, Executive |
| Jason Rubin | Director |
| Mark Velleca | Director |
| Christine Wyskiel | Director |
| Christina Wyskiel | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
15601 Crabbs Branch Way
Rockville, MD, 20855
Rockville, MD, 20855